Xtide 40mg Capsule

Xtide 40mg Capsule

Prescription requiredRx Required

Salt Composition: Enzalutamide

Expiry Date: 01/2028

Special offer

Price on Request

Price on Request

Inclusive of all taxes

28 Capsules In a Strip

About The Product

Prostate Cancer

Description

Xtide 40mg Tablet is an anticancer medicine. It contains Enzalutamide as an active ingredient that belongs to the second-generation nonsteroidal antiandrogen class of drugs.

It prescribes to treat prostate cancer in men at various stages. It may also be used to treat some other conditions like PCOS, as determined by the doctor.

Glenza works by blocking the effects of male hormones such as testosterone to slow down the growth and multiplication of cancer cells. It should be taken in dose and duration as advice by the doctor.

Don't take more than the recommended dose

Uses

  • Prostate cancer
  • Polycystic ovarian syndrome (PCOS)
  • Excessive hair growth

Side Effects

Xtide 40mg Capsule may cause some side effects that vary from one patient to another. Most side effects do not require any medical attention and disappear as your body adjusts to the medicine.
Common side effects include:

  • Headache
  • Hot flashes
  • Weakness
  • High blood pressure
  • Fatigue
  • Decreased appetite
  • Constipation
  • Dry skin
  • Itching
  • Fall
  • Fracture

Seek medical attention in case of any unusual or severe side effects immediately.

How To Use

  • Take Xtide 40mg Tablet in exact dose as prescribed by the doctor. The typical dose of this capsule varies with age and overall health factor of the patient. It can be taken with or without food but at a fixed time each day to get better results.
  • It should be swallowed as a whole with water without crushing, chewing, or opening the capsule. Don't miss a dose or overdose the medicine.

How It Works

  • Xtide 40mg Tablet contains Enzalutamide as an active ingredient that belongs to the second-generation nonsteroidal antiandrogen class of drugs.
  • It works by blocking the action of a particular enzyme to reduce the production of male hormone like testosterone. As a result, by controlling the production of hormone it slows down the progression of cancer.

Safety Advice

Alcohol
Avoid the consumption of alcohol while taking Xtide 40mg Capsule, as alcohol can decrease the effectiveness of the medicine as well as worsen the symptoms.
Pregnancy
Do not take Xtide 40mg Capsule without consulting the doctor in case of pregnancy, as it can be unsafe to take it during this period.
Breast Feeding
Breastfeeding women should discuss the potential risks and benefits of the Xtide 40mg Capsule with their healthcare provider before starting treatment.
Driving
Breastfeeding women should discuss the potential risks and benefits of the Xtide 40mg Capsule with their healthcare provider before starting treatment.
Kidney
Share your medical history with the doctor before starting the Xtide 40mg Capsule. Do not take it without consulting a doctor if you have any kidney related issue.
Liver
Share your medical history with the doctor before starting the Xtide 40mg Capsule. Do not take it without consulting a doctor if you have any liver related issue.

FAQs

Xtide 40mg Tablet is an anti-cancer medication that is prescribed for the treatment of Prostate cancer.

It works by blocking the effect of testosterone.

References

  • Freedland, S. J., de Almeida Luz, M., De Giorgi, U., Gleave, M., Gotto, G. T., Pieczonka, C. M., ... & Shore, N. D. (2023). Improved outcomes with enzalutamide in biochemically recurrent prostate cancer. New England Journal of Medicine, 389(16), 1453-1465. https://pubmed.ncbi.nlm.nih.gov/37851874/
  • Hoffman-Censits, J., & Kelly, W. K. (2013). Enzalutamide: a novel antiandrogen for patients with castrate-resistant prostate cancer. Clinical Cancer Research, 19(6), 1335-1339. https://pubmed.ncbi.nlm.nih.gov/23300275/
  • Claessens, F., Helsen, C., Prekovic, S., Van den Broeck, T., Spans, L., Van Poppel, H., & Joniau, S. (2014). Emerging mechanisms of enzalutamide resistance in prostate cancer. Nature reviews urology, 11(12), 712-716. https://pubmed.ncbi.nlm.nih.gov/25224448/
  • Davis, I. D., Martin, A. J., Stockler, M. R., Begbie, S., Chi, K. N., Chowdhury, S., ... & Sweeney, C. J. (2019). Enzalutamide with standard first-line therapy in metastatic prostate cancer. New England Journal of Medicine, 381(2), 121-131. https://pubmed.ncbi.nlm.nih.gov/31157964/
  • Beer, T. M., Armstrong, A. J., Rathkopf, D. E., Loriot, Y., Sternberg, C. N., Higano, C. S., ... & Tombal, B. (2014). Enzalutamide in metastatic prostate cancer before chemotherapy. New England Journal of Medicine, 371(5), 424-433. https://pubmed.ncbi.nlm.nih.gov/24881730/

i
Trust & safety

Medical Disclaimer

Accurate, reviewed information to support informed healthcare decisions

For informational purposes only
Not a substitute for professional medical advice
Consult your doctor for diagnosis and treatment

Magicine's primary objective is to ensure that its customers receive accurate, genuine, and trustworthy information reviewed by medical experts.

The content on this website has been produced solely for informational purposes. This is not intended to take the place of medical advice and care provided by a licensed professional, though.

This information may not include all potential side effects, warnings, and details about specific lab tests, medications, and medical conditions. Please ask your doctor any questions you may have about any drug or disease.

Our goal is not to replace or substitute for the doctor-patient relationship, but to uphold and strengthen it.

Always follow advice from your doctor, pharmacist, or other licensed healthcare professional before starting, stopping, or changing any medicine or treatment.
Magicine PharmacopyCopyright 2026